Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Common Equity (2019 - 2025)

Historic Common Equity for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $127.0 million.

  • Outset Medical's Common Equity rose 37336.59% to $127.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $127.0 million, marking a year-over-year increase of 37336.59%. This contributed to the annual value of $127.0 million for FY2025, which is 37336.59% up from last year.
  • Latest data reveals that Outset Medical reported Common Equity of $127.0 million as of Q4 2025, which was up 37336.59% from $142.4 million recorded in Q3 2025.
  • In the past 5 years, Outset Medical's Common Equity registered a high of $431.2 million during Q2 2021, and its lowest value of $26.8 million during Q4 2024.
  • Over the past 5 years, Outset Medical's median Common Equity value was $176.5 million (recorded in 2023), while the average stood at $210.3 million.
  • Per our database at Business Quant, Outset Medical's Common Equity crashed by 7817.57% in 2024 and then soared by 37336.59% in 2025.
  • Quarter analysis of 5 years shows Outset Medical's Common Equity stood at $374.1 million in 2021, then tumbled by 34.24% to $246.0 million in 2022, then plummeted by 50.04% to $122.9 million in 2023, then crashed by 78.18% to $26.8 million in 2024, then skyrocketed by 373.37% to $127.0 million in 2025.
  • Its Common Equity was $127.0 million in Q4 2025, compared to $142.4 million in Q3 2025 and $154.8 million in Q2 2025.